Navigation Links
State-of-the Art in Alzheimer's Research Featured at 25th Conference of Alzheimer's Disease International
Date:3/4/2010

LONDON, March 4, 2010 /PRNewswire/ -- "What's new" in Alzheimer's disease medical treatments and diagnosis is the focus of the first day's plenary sessions at the 25th International Conference of Alzheimer's Disease International (ADI), March 11, 2010 at the Grand Hotel Palace, Thessaloniki, Greece.

Sam Gandy, M.D., Ph.D. of Mount Sinai Alzheimer's Disease Research Center, New York, will address "New Treatment Developments" in Alzheimer's, including therapies that have the greatest potential for entering clinical practice in the next few years - bapineuzumab, latrepirdine, and gamma secretase inhibitors. He also will touch on intriguing science that may explain the link between Alzheimer's and diabetes.

"Neuroimaging Perspectives" is the topic of Prof. Frank Jessen of the University of Bonn, Germany. The presentation will cover recent advances in both magnetic resonance imaging (MRI) and positron emission tomography (PET) in Alzheimer's. In particular, how the two technologies have contributed substantially to both better diagnosis and understanding the progression of the disease.

Pieter Jelle Visser, M.D. of Maastricht University Medical Centre and VU University Medical Centre, Amsterdam, The Netherlands will cover "MCI and the Early Diagnosis of Alzheimer's Disease." Mild cognitive impairment (MCI) refers to cognitive impairment not severe enough to meet the criteria of dementia. Using biomarkers and cognitive testing, it is possible to estimate the risk that a person with MCI will progress to Alzheimer's. Visser will provide an overview of markers for Alzheimer's in people with MCI and discuss how they may prove useful in clinical research, earlier diagnosis and treatment.

Bengt Winblad, M.D., Ph.D., of the Karolinska Institutet, Stockholm and Karolinska University, Huddinge, Sweden, will speak on "Ongoing clinical trials in Alzheimer's disease."

The day's second plenary session will focus on the "Global Alzheimer's Movement." Other plenaries will focus on treatments without drugs, and best practices in dementia care. For more information, visit http://www.adi2010.org/

ADI is working closely with the Greek Association of Alzheimer's Disease and Related Disorders in organizing this conference.

Alzheimer's Disease International is an international federation of 71 Alzheimer associations around the world, in official relations with the World Health Organization. ADI's mission is to improve the quality of life of people with dementia and their families throughout the world. Please visit http://www.alz.co.uk/adi/.

Contacts:

Niles Frantz, Alzheimer's Association (Chicago), +1-312-335-5777, niles.frantz@alz.org

Marc Wortmann, Alzheimer's Disease International (London), +44-20-7981-0880, m.wortmann@alz.co.uk

SOURCE Alzheimer's Disease International

Back to top
'/>"/>
SOURCE Alzheimer's Disease International
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. A Top Cosmetic Dentistry Practice in Central New Jersey Announces Launch of New, State-of-the-Art Website
2. New Provider of Tablet/Capsule Packaging Solutions For Offers State-of-the-Art Equipment In The United States & Mexico
3. Long Island Plastic Surgical Practice - the Largest in the U.S. - Opens Virtual Doors on a New, State-of-the-Art Website
4. UCSF Medical Center Orders Three RIVA Systems for State-of-the-Art Pharmacy Facility
5. Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care
6. Epilepsy patients caught in treatment gap are not getting state-of-the-art care
7. Richmond, Virginia Plastic Surgeon Launches State-of-the-Art Breast Surgery Website
8. Bay Area Plastic Surgeon Reaches Out to Patients with New, State-of-the-Art Website
9. Nicky Hambleton-Jones Supports Launch of State-of-the-Art London Cosmetic Surgery Clinic
10. LASIK Eye Surgeons in San Diego Announce Launch of New, State-of-the-Art Website
11. The Help Group Summit on Autism, Learning Disabilities, and ADHD Features State-of-the-Art Research and Best Practices in Education and Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... ... ... Establishment Labs, a global breast implant and medical technology company, is pleased ... , “We are honored to welcome David to our Board of Directors. ... Quiros, CEO of Establishment Labs. "David’s knowledge and experience will be invaluable to our ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... service to expand access to affordable hearing aids , increase industry transparency, ... individuals in the United States. , “For the average consumer, the hearing aid ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... sealing company , is proud to announce that many of their franchises have ... customer service. The hard surface restoration franchises received customer recognition through positive reviews ...
(Date:2/8/2016)... ... February 08, 2016 , ... The Federal Laboratory ... federallabs.org . The site houses a wealth of federal resources that businesses can ... process called technology transfer (T2). As a network of over 300 federal laboratories, ...
(Date:2/8/2016)... Los Angeles, CA (PRWEB) , ... February 08, 2016 , ... A man who has ... CEO of Freedom Laser Therapy , was determined to find solutions to his problems ... story of Inventors Digest is ready to introduce his breakthrough inventions to the ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... , February 9, 2016 ... QIA) gab heute den Abschluss eines Kooperationsvertrags ... Förderung umfassender Lösungen in den Bereichen Next-Generation-Sequencing ... QGEN ; Frankfurt Prime Standard: QIA) ... 10x Genomics für die Entwicklung und Förderung ...
(Date:2/9/2016)... 9, 2016 Mast Therapeutics, Inc. (NYSE ... sickle cell disease and heart failure, today announced that it ... purchase common stock in an underwritten public offering.  The offering ... be no assurance as to whether or when the offering ... terms of the offering.   --> ...
(Date:2/9/2016)... 9, 2016 Hearing protection devices refer to ... transmitted to the inner ear. Hearing protection devices include ... devices are recommended for users exposed to noise levels ... to HPD that are inserted in the ear canal ... to provide more natural sound perception with the help ...
Breaking Medicine Technology: